Stocks
Ultragenyx Pharmaceutical Inc.RARE
NASDAQHealthcareBiotechnology$21.34-1.70%
Price as of · delayed, not real-time
Focused on developing novel therapies for rare and ultra-rare genetic diseases, this biopharmaceutical company has a pipeline targeting conditions with high unmet medical need. Investors monitor its clinical-stage candidates and commercialization of approved products like Crysvita for X-linked hypophosphatemia.
Market Cap: $2.1B52W Range: $18.41 – $42.37
Congressional Interest in Ultragenyx Pharmaceutical Inc. (RARE)
2 members of Congress have disclosed 5 trades in Ultragenyx Pharmaceutical Inc. (RARE), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
5
Sells
0
Who in Congress Is Trading RARE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-02-18 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-08-08 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-07-15 | Gilbert Cisneros | buy | $1K – $15K |
| 2021-08-30 | Kurt Schrader | buy | $1K – $15K |